Seasonal influenza vaccination among cancer patients: A systematic review and meta-analysis of the determinants

Okoli, George N; Lam, Olt; Abdulwahid, Tiba; Neilson, Christine; Mahmud, Salaheddin M.; Abou‐Setta, Ahmed M

doi:10.1016/j.currproblcancer.2020.100646

Cited by 8 publications

(3 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We attempted to conduct a multivariate analysis, but due to small sample size in some cancer types, the multivariable models did not converge to give adjusted prevalence estimates. Nonetheless, our results would support the conclusion achieved by a recent meta-analysis by Okoli et al in that socioeconomic factors may also affect influenza vaccine uptake among cancer patients [ 10 ]. However, further studies are needed to determine how disparities related to age, sex, race, and insurance status operate differently among patients with specific solid or hematologic malignancies.…”

Section: Discussionsupporting

confidence: 91%

“…Despite recommendations from multiple societies, prior studies showed that the influenza vaccination rate in adults with cancer is similar to that in the United States (US) general population at approximately 40% [ 7–9 ]. However, these studies were limited by small sample sizes and cover only few specific cancer diagnoses [ 10 ]. Understanding vaccine uptake among individuals with different types of cancer is important because different cancers cause different degrees of immunosuppression.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey

Chang

Ellingson

Flowers

et al. 2021

Open Forum Infectious Diseases

View full text Add to dashboard Cite

Background Annual influenza vaccination is recommended for all patients with cancer but vaccine uptake data by cancer type and time since diagnosis is limited. We sought to estimate the vaccination rates across different cancer types in the United States and determine whether rates vary over time since diagnosis. Methods Vaccination rates in individuals with solid tumor and hematological malignancies were estimated using data from 59,917 individuals obtained by the 2016 and 2017 National Health Interview Survey (NHIS) conducted by the Centers for Disease Control and Prevention. Results An average of 64% of the 5,053 individuals with self-reported cancer received the influenza vaccine. Vaccination rates in men and women with solid tumors (66.6% and 60.3%) and hematological malignancies (58.1% and 59.2%) were significantly higher compared to those without cancer (38.9% and 46.8%). Lower rates were seen in uninsured, those younger than 45 years of age, and in African Americans with hematological malignancies but not with solid tumors. Vaccine uptake was similar regardless of time since cancer diagnosis. Conclusions Influenza vaccination rates are higher in men and women with cancer but remain suboptimal, highlighting the need for additional measures to improve vaccine compliance and prevent complications from influenza across all cancer types.

show abstract

Section: Discussionsupporting

confidence: 91%

mentioning

confidence: 99%

Influenza Vaccination Rates Among Patients With a History of Cancer: Analysis of the National Health Interview Survey

Chang

Ellingson

Flowers

et al. 2021

Open Forum Infectious Diseases

View full text Add to dashboard Cite

show abstract

“…In addition, this system exhibited desirable specificity with a low detection limit of ∼12 IU/mL. Seasonal influenza is a highly infectious and fast-spreading respiratory disease. − Efforts have been made in developing accurate and rapid POC influenza diagnostic tests. − Microchips have attracted tremendous attention because this system enabled the integration of multiple laboratory processes into simple platforms with high reaction efficiency. A polycarbonate (PC)–polydimethylsiloxane (PDMS) hybrid microchip with an epoxy silica sol–gel coating was fabricated to detect influenza virus with europium NPs (EuNPs) .…”

Section: Microscale Systems “See” In Virusesmentioning

confidence: 99%